Peripheral Angioplasty Market Size was valued at USD 3.6 Billion in 2022. The Peripheral Angioplasty industry is projected to grow from USD 3.9 Billion in 2023 to USD 7.14 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.90% during the forecast period (2024 - 2032). Increased obesity, diabetes, sedentary lifestyles, and aging populations are the key market drivers boosting the expansion of the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for Peripheral Angioplasty is being driven by the Growing Number of Elderly People. Narrowed arteries in peripheral arterial disease (PAD) limit blood flow to the limbs. PAD is a common circulatory condition. The arteries that bring blood from the heart to the brain, arms, kidneys, and stomach are occasionally affected by PAD, but primarily the arteries in the legs are affected. It is brought on by fat deposits (plaques) in the artery walls, which lower blood flow to the head, limbs, and organs.
Additionally, peripheral angioplasty treatments are in high demand to open blocked or narrowed arteries and restore blood flow because of the rising prevalence of peripheral artery disease (PAD), which includes atherosclerosis and is more common in the elderly population. Peripheral angioplasty operations are becoming more successful and effective because to ongoing improvements in angioplasty techniques, including the creation of drug-coated balloons, atherectomy devices, and enhanced stent technology. Peripheral angioplasty has become more popular since patients and medical professionals find that minimally invasive procedures have fewer side effects, quicker recovery periods, and fewer hospital stays than standard surgeries. The prevalence of peripheral arterial disorders is higher in the aging population. Peripheral angioplasty is one intervention that is becoming more and more necessary as this demographic keeps growing.
The incidence of peripheral arterial disorders is influenced by lifestyle-related factors such obesity, diabetes, and hypertension. Peripheral angioplasty is one intervention that is necessary to treat associated arterial blockages and stenosis. Peripheral angioplasty market expansion is aided by government programs that support enhanced access to healthcare, better healthcare infrastructure, and investments in cutting-edge medical technologies. Peripheral angioplasty procedures are increasingly accessible to patients due to favorable reimbursement regulations that incentivize healthcare professionals to offer them. Peripheral angioplasty device innovation is fueled by competition among medical device makers, which leads to the creation of more sophisticated and potent devices and more treatment alternatives for patients.
For instance, peripheral artery disease (PAD) affects over 6.5 million adults in North America who are 40 years of age and older. This information comes from the Centers for Disease Control and Prevention (CDC). Some of the main high-risk factors that lead to an increase in new PAD cases ly are smoking, coronary artery disease diabetes, high blood pressure, and cholesterol. Thus, result in driving the Peripheral Angioplasty market revenue.
The Peripheral Angioplasty market segmentation, based on Product includes Balloon Catheters, Stents, and Guidewires. The balloon catheters segment dominated the market. A key element of peripheral angioplasty treatments are balloon catheters. In order to restore blood flow to the afflicted location, they are utilized to widen constricted or blocked blood vessels in the peripheral arteries. Balloon catheters are a vital instrument in the field of peripheral angioplasty because of their efficacy in producing vessel dilatation.
The Peripheral Angioplasty market segmentation, based on End User, includes Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Centers. The hospitals category generated the most income. Hospitals have the equipment and facilities needed to carry out peripheral angioplasty treatments. They have dedicated catheterization labs with cutting-edge imaging tools like fluoroscopy and angiography, which help with accurate visualization and guiding during the process. Peripheral angioplasty services are made available to patients by institutions having these cutting-edge treatment facilities accessible to them.
Figure1: Peripheral Angioplasty Market, by End User, 2024 & 2032(USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Peripheral Angioplasty market area will dominate this market. This is because the market is driven by factors including rising rates of cardiovascular illnesses and an aging population. Additionally, the market is growing as a result of the rising number of cardiovascular disease cases in the United States. Moreover, the bulk of the significant industry participants are present in North America.
Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.
Figure2: PERIPHERAL ANGIOPLASTY MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Peripheral Angioplasty market has the second-largest portion of the market. This is due to an increase in the aging population in the region. Further, the German Peripheral Angioplasty market had the biggest market share, and the UK Peripheral Angioplasty market was the European market with the quickest rate of growth.
The Asia-Pacific Peripheral Angioplasty Market is anticipated to expand between 2024 and 2032 at the quickest CAGR. This is due to the growing prevalence of diabetes, which raises the risk of peripheral vascular diseases. Moreover, China’s Peripheral Angioplasty market had the biggest market share, and the Indian Peripheral Angioplasty market was the Asia-Pacific region's fastest-growing market.
Peripheral Angioplasty Key Market Players& Competitive Insights
Leading market players are putting a lot of money on R&D to expand their product lines, which will drive the peripheral angioplasty market's expansion. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Peripheral Angioplasty industry must provide reasonably priced goods.
Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the Peripheral Angioplasty industry to help customers and expand the market segment. In recent years, the Peripheral Angioplasty industry has provided some of the biggest benefits to medicine. Major players in the Peripheral Angioplasty market, including Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, and others, are engaging in research and development activities in an effort to boost market demand.
Boston Scientific Corporation ("BSC") is a worldwide biomedical/biotechnology engineering company that produces medical devices for use in a variety of interventional medical disciplines, such as interventional cardiology and radiology. On June 29, 1979, Boston Scientific was established in Watertown, Massachusetts, forty-four years ago, as a holding company for Medi-Tech, Inc., a medical goods company, with the goal of positioning the latter for expansion into the field of interventional medicine. Itzhak Bentov, a Czech who immigrated to Israel and later the US, was the creator of Medi-Tech. In January 2021, Boston declared that it will pay up to $1.2 billion to acquire Minneapolis-based Preventice Solutions, Inc. and its suite of mobile heart health solutions.
Abbott Laboratories is a worldwide medical equipment and healthcare firm. In addition to selling medical equipment, diagnostics, branded generic medications, and nutritional goods, the company was established in 1888 by Chicago physician Wallace Calvin Abbott to develop well-known drugs. In 2013, it divided into AbbVie and separated its research-based pharmaceutical division. MitraClip, Glucerna, Ensure, ZonePerfect, FreeStyle Libre, i-STAT, Similac, Pedialyte, and BinaxNOW are among the products made by Abbott. In January 2022, Abbott unveiled Lingo, a set of consumer biowearable sensors that gathers biological data to enhance diet and exercise plans.
Key Companies in the Peripheral Angioplasty market include
Peripheral Angioplasty Industry Developments
June 2022: Cardio Flow, Inc. is a medical device business that produces less invasive peripheral vascular gadgets for peripheral artery disease treatment (PAD). The company recently announced that the FreedomFlow Peripheral Guidewire it makes has received FDA approval.
January 2022: Cook Medical was awarded breakthrough device designation by the FDA in the United States for a unique drug-eluting below-the-knee (BTK) stent. The purpose of this novel stent is to treat patients with chronic ischemia that poses a hazard to their limbs.
May 2022:Medtronic stated that the USA Food and Drug Administration (FDA) has approved the IN. PACTTM paclitaxel-coated percutaneous transluminal angioplasty device, also known as the Balloon Catheter.
| Report Attribute/Metric | Details |
| Market Size2022 | USD 3.6 Billion |
| Market Size 2023 | USD 3.9 Billion |
| Market Size2032 | USD 7.14 Billion |
| Compound Annual Growth Rate (CAGR) | 7.90% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, End User, and Region |
| Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Â Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, and Boston Scientific Corporation |
| Key Market Opportunities | ·        Government programs encouraging improved infrastructure for healthcare |
| Key Market Dynamics | ·        Peripheral angioplasty device innovation is driven by competition among medical device makers. |
Frequently Asked Questions (FAQ) :
In 2022, the size of the worldwide peripheral angioplasty market was estimated to be USD 3.6 billion.
From 2024 to 2032, The(CAGR) for the market is predicted to be 7.90%.
North America held the most market share worldwide.
Edwards Lifesciences Corporation, B. Braun Melsungen AG, Cook Medical, Johnson & Johnson, Terumo Corporation, Medtronic, Abbott Laboratories, and Boston Scientific Corporation are the major participants in the industry.
In 2022, the market was dominated by the balloon catheter category.
The biggest market share worldwide belonged to hospitals.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
